BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38010064)

  • 41. The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.
    Liu X; Lu Y; Zhu G; Lei Y; Zheng L; Qin H; Tang C; Ellison G; McCormack R; Ji Q
    J Clin Pathol; 2013 Dec; 66(12):1065-9. PubMed ID: 23888061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients.
    Xu C; Yu L; Zhan P; Zhang Y
    Eur J Med Res; 2014 May; 19(1):23. PubMed ID: 24887477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. mRNA markers associated with malignant pleural effusion.
    Hsu SC; Chang SY; Hwang YT; Terng HJ; Tsai CL; Shen CH; Huang SK; Chian CF
    Sci Rep; 2023 Apr; 13(1):6677. PubMed ID: 37095178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
    Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
    J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
    Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutant KRAS promotes malignant pleural effusion formation.
    Agalioti T; Giannou AD; Krontira AC; Kanellakis NI; Kati D; Vreka M; Pepe M; Spella M; Lilis I; Zazara DE; Nikolouli E; Spiropoulou N; Papadakis A; Papadia K; Voulgaridis A; Harokopos V; Stamou P; Meiners S; Eickelberg O; Snyder LA; Antimisiaris SG; Kardamakis D; Psallidas I; Marazioti A; Stathopoulos GT
    Nat Commun; 2017 May; 8():15205. PubMed ID: 28508873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Establishment of a malignant pleural effusion mouse model with Lewis lung carcinoma cell lines expressing enhanced green fluorescent protein].
    Ma X; Sun Y; Wang S; Yang Z; Song Y
    Zhongguo Fei Ai Za Zhi; 2012 Jun; 15(6):317-23. PubMed ID: 22681917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients.
    Shin S; Kim J; Kim Y; Cho SM; Lee KA
    Clin Chem Lab Med; 2017 Oct; 55(12):1962-1969. PubMed ID: 28306520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
    Bao Q; Xu Y; Ding M; Chen P
    Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature.
    Mori R; Fujimoto D; Ito M; Tomii K
    Oncotarget; 2017 Jul; 8(29):48521-48524. PubMed ID: 28591698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
    Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
    Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
    Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma. The Effect of Preanalytical Factors.
    Carter J; Miller JA; Feller-Kopman D; Ettinger D; Sidransky D; Maleki Z
    Ann Am Thorac Soc; 2017 Jul; 14(7):1169-1176. PubMed ID: 28557526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.
    Zhang T; Liu W; Li L; Jue Z; Xu C
    BMC Pulm Med; 2022 Aug; 22(1):307. PubMed ID: 35948914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.
    Tsai MF; Chang TH; Wu SG; Yang HY; Hsu YC; Yang PC; Shih JY
    Sci Rep; 2015 Sep; 5():13574. PubMed ID: 26338423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
    Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
    J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation.
    Zou J; Bella AE; Chen Z; Han X; Su C; Lei Y; Luo H
    J Int Med Res; 2014 Oct; 42(5):1110-7. PubMed ID: 25239875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A Method for Isolating Tumor Cells from Large Volume of Malignant Pleural 
Effusion and Its Efficacy Evaluation].
    Wang Y; Liang Z; Liu Y; Kou F; Jiang D; Zheng Y; Liu W; Zhu B
    Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1080-1086. PubMed ID: 33357315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of cancer stem cell-related marker expression is associated with three-dimensional structures in malignant pleural effusion produced by lung adenocarcinoma.
    Lin YY; Lin YS; Liang CW
    Cytopathology; 2024 Jan; 35(1):105-112. PubMed ID: 37897199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.
    Niu Y; Zhou Q
    Cell Mol Life Sci; 2022 Mar; 79(4):194. PubMed ID: 35298721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.